
Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone
Takeda Pharmaceutical Co said on Monday it would sell its Japanese consumer healthcare business to U.S. buyout fund Blackstone Group, as it aims to focus on developing drugs for unmet …
Read More